The promise of endogenous and exogenous riboflavin in anti-infection

References

• Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006 4(1):36–45. PMID: 16357859.
   PubMed Web of Science ®Google Scholar
• Xiao YH, Giske CG, Wei ZQ, et al. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat. 2011 ;14(4–5):236–250. PMID: 21807550.
   PubMed Web of Science ®Google Scholar
• Fisher MC, Hawkins NJ, Sanglard D, et al. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018 ;360(6390):739–742. PMID: 29773744.
   PubMed Web of Science ®Google Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017 Dec;17(12):e383–e392. PMID: 28774698.
   PubMed Web of Science ®Google Scholar
• Devi U, Locarnini S. Hepatitis B antivirals and resistance. Curr Opin Virol. 2013 ;3(5):495–500. PMID: 24016777.
   PubMed Web of Science ®Google Scholar
• Lampejo T. Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis. 2020;39(7):1201–1208. PMID: 32056049.
   PubMed Web of Science ®Google Scholar
• McKeegan KS, Borges-Walmsley MI, Walmsley AR. Microbial and viral drug resistance mechanisms. Trends Microbiol. 2002;10(10Suppl):S8–14. PMID: 12377562
   PubMedGoogle Scholar
• Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance. prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383–e392. PMID: 28774698
   PubMed Web of Science ®Google Scholar
• Waglechner N, Wright GD. Antibiotic resistance: it’s bad, but why isn’t it worse? BMC Biol. 2017;15(1):84. PMID: 28915805
   PubMedGoogle Scholar
• Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18(6):319–331. PMID: 32047294
   PubMed Web of Science ®Google Scholar
• Fuller AT. Is p-aminobenzenesulphonamide the active agent of prontosil therapy? Lancet. 1937;229(5917):194–198.
   Google Scholar
• Guzzo MB, Nguyen HT, Pham TH, et al. Methylfolate trap promotes bacterial thymineless death by sulfa drugs. PLoS Pathog. 2016;12(10):e1005949. PMID: 27760199
   PubMed Web of Science ®Google Scholar
• Bertacine Dias MV, Santos JC, Libreros-Zúñiga GA, et al. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases. Future Med Chem. 2018;10(8):935–959. PMID: 29629843
   PubMed Web of Science ®Google Scholar
• Parente-Rocha JA, Bailão AM, Amaral AC, et al. Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi. Mediators Inflamm. 2017;2017:1-16. PMID: 28694566.
   PubMed Web of Science ®Google Scholar
• Pedrolli D, Langer S, Hobl B, et al. The ribB FMN riboswitch from Escherichia coli operates at the transcriptional and translational level and regulates riboflavin biosynthesis. FEBS. 2015;282(16):3230–3242. PMID: 25661987
   PubMed Web of Science ®Google Scholar
• Kundu B, Sarkar D, Ray N, et al. Understanding the riboflavin biosynthesis pathway for the development of antimicrobial agents. Med Res Rev. 2019;39(4):1338–1371. PMID: 30927319
   PubMed Web of Science ®Google Scholar
• Pinto JT, Zempleni J. Riboflavin. Adv Nutr. 2016;7(5):973–975. PMID: 27633112
   PubMed Web of Science ®Google Scholar
• Thakur K, Tomar SK, Singh AK, et al. Riboflavin and health: a review of recent human research. Crit Rev Food Sci Nutr. 2017;57(17):3650–3660. PMID: 27029320
   PubMed Web of Science ®Google Scholar
• Flieger M, Bandouchova H, Cerny J, et al. Vitamin B2 as a virulence factor in Pseudogymnoascus destructans skin infection. Sci Rep. 2016;6:33200. PMID: 27620349
   PubMed Web of Science ®Google Scholar
• Toyosawa T, Suzuki M, Kodama K, et al. Effects of intravenous infusion of highly purified vitamin B2 on lipopolysaccharide-induced shock and bacterial infection in mice. Eur J Pharmacol. 2004;492(2–3):273–280. PMID: 15178375
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Kolaczkowska E, Plytycz B. Modulation of zymosan-induced peritonitis by riboflavin co-injection, pre-injection or post-injection in male Swiss mice. Life Sci. 2012;91(25–26):1351–1357. PMID: 23123448
   PubMed Web of Science ®Google Scholar
• Fischer M, Bacher A. Biosynthesis of flavocoenzymes. Nat Prod Rep. 2005;22(3):324–350. PMID: 25635378
   PubMed Web of Science ®Google Scholar
• Bacher A, Eberhardt S, Fischer M, et al. Biosynthesis of vitamin b2 (riboflavin). Annu Rev Nutr. 2000;20:153–167. PMID: 10940330
   PubMed Web of Science ®Google Scholar
• Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart. 2012;33(7):829–37, 837a-837d. PMID: 21890489
   PubMed Web of Science ®Google Scholar
• Liu S, Hu W, Wang Z, et al. Production of riboflavin and related cofactors by biotechnological processes. Microb Cell Fact. 2020;19(1):31. PMID: 32054466
   PubMed Web of Science ®Google Scholar
• Cecchini G, Perl M, Lipsick J, et al. Transport and binding of riboflavin by Bacillus subtilis. J Biol Chem. 1979 Aug 10;254(15):7295–7301. PMID: 110806.
   PubMed Web of Science ®Google Scholar
• Schneider C, Mack M. A second riboflavin import system is present in flavinogenic Streptomyces davaonensis and supports roseoflavin biosynthesis. Mol Microbiol. 2021 Apr 7. 10.1111/mmi.14726. PMID: 33829573.
   Web of Science ®Google Scholar
• Vitreschak AG, Rodionov DA, Mironov AA, et al. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res. 2002 Jul 15;30(14):3141–3151. PMID: 12136096.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Preciado A, Torres AG, Merino E, et al. Extensive Identification of Bacterial Riboflavin Transporters and Their Distribution across Bacterial Species. PLoS One. 2015 May 4;10(5):e0126124. PMID: 25938806.
   PubMed Web of Science ®Google Scholar
• Abbas CA, Sibirny AA. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev. 2011;75(2):321–360. PMID: 21646432
   PubMed Web of Science ®Google Scholar
• Perl M, Kearney EB, Singer TP. Transport of riboflavin into yeast cells. J Biol Chem. 1976 Jun 10;251(11):3221–3228. PMID: 6447.
   PubMed Web of Science ®Google Scholar
• Reihl P, Stolz J. The monocarboxylate transporter homolog Mch5p catalyzes riboflavin (vitamin B2) uptake in Saccharomyces cerevisiae. J Biol Chem. 2005 Dec 2; Epub 2005 Oct 4. 280(48):39809–39817. PMID: 16204239.
   PubMed Web of Science ®Google Scholar
• Barile M, Giancaspero TA, Leone P, et al. Riboflavin transport and metabolism in humans. J Inherit Metab Dis. 2016 Jul;39(4):545–557; Epub 2016 Jun 6. PMID: 27271694.
   PubMed Web of Science ®Google Scholar
• Krajewski SS, Ignatov D, Johansson J. Two are better than one: dual targeting of riboswitches by metabolite analogs. Cell Chem Biol. 2017;24(5):535–537. PMID: 28525764
   PubMed Web of Science ®Google Scholar
• Blount KF, Breaker RR. Riboswitches as antibacterial drug targets. Nat Biotechnol. 2006;24(12):1558–1564. PMID: 17160062
   PubMed Web of Science ®Google Scholar
• Panchal V, Brenk R. Riboswitches as drug targets for antibiotics. Antibiotics. 2021;10(1):45. PMID: 33466288
   Google Scholar
• Howe JA, Wang H, Fischmann TO, et al. Selective small-molecule inhibition of an RNA structural element. Nature. 2015;526(7575):672–677. PMID: 26416753
   PubMed Web of Science ®Google Scholar
• Balibar CJ, Villafania A, Barbieri CM, et al. Validation and development of an Escherichia coli riboflavin pathway phenotypic screen hit as a small-molecule ligand of the flavin mononucleotide riboswitch. Methods Mol Biol. 2018;1787:19–40. PMID: 29736707
   PubMedGoogle Scholar
• Motika SE, Ulrich RJ, Geddes EJ, et al. Gram-negative antibiotic active through inhibition of an essential riboswitch. J Am Chem Soc. 2020;142(24):10856–10862. PMID: 32432858
   PubMed Web of Science ®Google Scholar
• Wang H, Mann PA, L X, et al. Dual-targeting small-molecule inhibitors of the Staphylococcus aureus FMN riboswitch disrupt riboflavin homeostasis in an infectious setting. Cell Chem Biol. 2017;24(5):576–588.e6.
   PubMed Web of Science ®Google Scholar
• Jankowitsch F, Schwarz J, Rückert C, et al. Genome sequence of the bacterium Streptomyces davawensis JCM 4913 and heterologous production of the unique antibiotic roseoflavin. Genome sequence of the bacterium Streptomyces davawensis JCM 4913 and heterologous production of the unique antibiotic roseoflavin. J Bacteriol. 2012;194(24):6818–6827. PMID: 23043000
   PubMed Web of Science ®Google Scholar
• Lee ER, Blount KF, Breaker RR. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol. 2009;6(2):187–194. PMID: 19246992
   PubMed Web of Science ®Google Scholar
• Serganov A, Huang L, Patel DJ. Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch. Nature. 2009;458(7235):233–237. PMID: 19169240
   PubMed Web of Science ®Google Scholar
• Mansjö M, Johansson J. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection. RNA Biol. 2011;8(4):674–680. PMID: 21593602
   PubMed Web of Science ®Google Scholar
• Matern A, Pedrolli D, Großhennig S, et al. Uptake and metabolism of antibiotics roseoflavin and 8-Demethyl-8-Aminoriboflavin in riboflavin-auxotrophic Listeria monocytogenes. J Bacteriol. 2016;198(23):3233–3243. PMID: 27672192
   PubMed Web of Science ®Google Scholar
• Pedrolli DB, Mack M. Bacterial flavin mononucleotide riboswitches as targets for flavin analogs. Methods Mol Biol. 2014;1103:165–176. PMID: 24318894
   PubMedGoogle Scholar
• Ott E, Stolz J, Lehmann M, et al. RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol. 2009;6(3):276–280. PMID: 19333008
   PubMed Web of Science ®Google Scholar
• Grill S, Busenbender S, Pfeiffer M, et al. The bifunctional flavokinase/flavin adenine dinucleotide synthetase from Streptomyces davawensis produces inactive flavin cofactors and is not involved in resistance to the antibiotic roseoflavin. J Bacteriol. 2008;190(5):1546–1553. PMID: 18156273
   PubMed Web of Science ®Google Scholar
• Pedrolli DB, Matern A, Wang J, et al. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis. Nucleic Acids Res. 2012;40(17):8662–8673. PMID: 22740651
   PubMed Web of Science ®Google Scholar
• Langer S, Hashimoto M, Hobl B, et al. Flavoproteins are potential targets for the antibiotic roseoflavin in Escherichia coli. J Bacteriol. 2013;195(18):4037–4045. PMID: 23836860
   PubMed Web of Science ®Google Scholar
• Pedrolli DB, Nakanishi S, Barile M, et al. The antibiotics roseoflavin and 8-demethyl-8-amino-riboflavin from Streptomyces davawensis are metabolized by human flavokinase and human FAD synthetase. Biochem Pharmacol. 2011;82(12):1853–1859. PMID: 21924249
   PubMed Web of Science ®Google Scholar
• Blount KF, Megyola C, Plummer M, et al. Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora. Antimicrob Agents Chemother. 2015;59(9):5736–5746. PMID: 26169403
   PubMed Web of Science ®Google Scholar
• Long Q, Ji L, Wang H, et al. Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets. Chem Biol Drug Des. 2010;75(4):339–347. PMID: 20148904
   PubMed Web of Science ®Google Scholar
• Bonomi HR, Marchesini MI, Klinke S, et al. An atypical riboflavin pathway is essential for Brucella abortus virulence. PLoS One. 2010;5(2):e9435. PMID: 20195542
   PubMed Web of Science ®Google Scholar
• Morgunova E, Saller S, Haase I, et al. Lumazine synthase from Candida albicans as an anti-fungal target enzyme: structural and biochemical basis for drug design. J Biol Chem. 2007;282(23):17231–17241. PMID: 17446177
   PubMed Web of Science ®Google Scholar
• Kumar P, Singh M, Karthikeyan S. Crystal structure analysis of icosahedral lumazine synthase from Salmonella typhimurium, an antibacterial drug target. Acta Crystallogr D Biol Crystallogr. 2011;67(Pt2):131–139. PMID: 21245535
   PubMedGoogle Scholar
• Chen J, Illarionov B, Bacher A, et al. A high-throughput screen utilizing the fluorescence of riboflavin for identification of lumazine synthase inhibitors. Anal Biochem. 2005;338(1):124–130. PMID: 15707942
   PubMed Web of Science ®Google Scholar
• Meir Z, Osherov N. Vitamin biosynthesis as an antifungal target. J Fungi. 2018;4(2):72. PMID: 29914189
   Web of Science ®Google Scholar
• Zhao Y, Bacher A, Illarionov B, et al. Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis. J Org Chem. 2009;74(15):5297–5303. PMID: 19545132
   PubMed Web of Science ®Google Scholar
• Serer MI, Carrica MDC, Trappe J, et al. A high-throughput screening for inhibitors of riboflavin synthase identifies novel antimicrobial compounds to treat brucellosis. FEBS J. 2019;286(13):2522–2535. PMID: 30927485
   PubMed Web of Science ®Google Scholar
• Cushman M, Jin G, Sambaiah T, et al. Design, synthesis, and biochemical evaluation of 1,5,6,7-tetrahydro-6,7-dioxo-9-D-ribitylaminolumazines bearing alkyl phosphate substituents as inhibitors of lumazine synthase and riboflavin synthase. J Org Chem. 2005;70(20):8162–8170. PMID: 16277343
   PubMed Web of Science ®Google Scholar
• Islam Z, Kumar A, Singh S, et al. Structural basis for competitive inhibition of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Vibrio cholerae. J Biol Chem. 2015;290(18):11293–11308. PMID: 25792735
   PubMed Web of Science ®Google Scholar
• Jin L, Zhou H, Zhao S, et al. Cloning and characterization of a new antibacterial target, 3,4-dihydroxy-2-butanone-4-phosphate synthase. Acta Microbiologica Sinica. 2012;52(11):1415–1420. PMID: 23383514.
   PubMedGoogle Scholar
• Li J, Hua Z, Miao L, et al. The crystal structure and biochemical properties of DHBPS from Streptococcus pneumoniae, a potential anti-infective target for Gram-positive bacteria. Protein Expr Purif. 2013;91(2):161–168. PMID: 23954596
   PubMed Web of Science ®Google Scholar
• Sebastián M, Velázquez-Campoy A, The MM. RFK catalytic cycle of the pathogen Streptococcus pneumoniae shows species-specific features in prokaryotic FMN synthesis. J Enzyme Inhib Med Chem. 2018;33(1):842–849. PMID: 29693467
   PubMed Web of Science ®Google Scholar
• Lans I, Anoz-Carbonell E, Palacio-Rodríguez K, et al. In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target. PLoS Computational Biology. 2020;16(8):e1007898. PMID: 32797038.
   Google Scholar
• Dietl AM, Meir Z, Shadkchan Y, et al. Riboflavin and pantothenic acid biosynthesis are crucial for iron homeostasis and virulence in the pathogenic mold Aspergillus fumigatus. Virulence. 2018;9(1):1036–1049. PMID: 30052132
   PubMed Web of Science ®Google Scholar
• Demuyser L, Palmans I, Vandecruys P, et al. Molecular elucidation of riboflavin production and regulation in Candida albicans, toward a novel antifungal drug target. mSphere. 2020;5(4):e00714–20. PMID: 32759338
   PubMed Web of Science ®Google Scholar
• Becker JM, Kauffman SJ, Hauser M, et al. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proc Natl Acad Sci USA. 2010;107(51):22044–22049. PMID: 21135205
   PubMed Web of Science ®Google Scholar
• Garfoot AL, Zemska O, Rappleye CA. Histoplasma capsulatum depends on de novo vitamin biosynthesis for intraphagosomal proliferation. Infect Immun. 2014 Jan;82(1):393–404; Epub 2013 Nov 4. PMID: 24191299.
   PubMed Web of Science ®Google Scholar
• de Castro PA, Chiaratto J, Morais ER, et al. The putative flavin carrier family FlcA-C is important for Aspergillus fumigatus virulence. Virulence. 2017;8(6):797–809. PMID: 27652896
   PubMed Web of Science ®Google Scholar
• Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. 2014;5:450. PMID: 25339949
   PubMed Web of Science ®Google Scholar
• Eckle SB, Corbett AJ, Keller AN, et al. Recognition of Vitamin B precursors and byproducts by mucosal associated invariant T cells. J Biol Chem. 2015;290(51):30204–30211. PMID: 26468291
   PubMed Web of Science ®Google Scholar
• Franciszkiewicz K, Salou M, Legoux F, et al. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Immunol Rev. 2016;272(1):120–138. PMID: 27319347
   PubMed Web of Science ®Google Scholar
• Keller AN, Corbett AJ, Wubben JM, et al. MAIT cells and MR1-antigen recognition. Curr Opin Immunol. 2017;46:66–74. PMID: 28494326
   PubMed Web of Science ®Google Scholar
• Constantinides MG, Link VM, Tamoutounour S, et al. MAIT cells are imprinted by the microbiota in early life and promote tissue repair. Science. 2019;366(6464):eaax6624. PMID: 31649166
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, D’Souza C, et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. 2017;10(1):58–68. PMID: 27143301
   PubMed Web of Science ®Google Scholar
• Wang H, D’Souza C, Lim XY et al. MAIT cells protect against pulmonary Legionella longbeachae infection. Nature Communucations.2018;9(1):3350.
   Google Scholar
• Kurioka A, Ussher JE, Cosgrove C, et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015;8(2):429–440. PMID: 25269706
   PubMed Web of Science ®Google Scholar
• Sakala IG, Kjer-Nielsen L, Eickhoff CS, et al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T Cells specific for riboflavin metabolites. J Immunol. 2015;195(2):587–601. PMID: 26063000
   PubMed Web of Science ®Google Scholar
• Bucsan AN, Rout N, Foreman TW, et al. Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551. Tuberculosis. 2019;116S:S11–S18. PMID: 31072689
   PubMedGoogle Scholar
• Napier RJ, Adams EJ, Gold MC, et al. The role of mucosal associated invariant T Cells in antimicrobial immunity. Front Immunol. 2015;6:344. PMID: 26217338
   PubMed Web of Science ®Google Scholar
• Le Bourhis L, Martin E, Péguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010;11(8):701–708. PMID: 20581831
   PubMed Web of Science ®Google Scholar
• Jahreis S, Böttcher S, Hartung S, et al. Human MAIT cells are rapidly activated by Aspergillus spp. in an APC-dependent manner. Eur J Immunol. 2018;48(10):1698–1706. PMID: 30059139
   PubMed Web of Science ®Google Scholar
• Böttcher S, Hartung S, Meyer F, et al. Human mucosal-associated invariant T cells respond to Mucorales species in a MR1-dependent manner. Med Mycol. 2020:myaa103. DOI:10.1093/mmy/myaa103. PMID: 33336238.
   Web of Science ®Google Scholar
• Dias J, Leeansyah E, Sandberg JK. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci USA. 2017;114(27):E5434–E5443. PMID: 28630305
   PubMed Web of Science ®Google Scholar
• van Wilgenburg B, Loh L, Chen Z, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9(1):4706. PMID: 30413689
   PubMedGoogle Scholar
• van Wilgenburg B, Scherwitzl I, Hutchinson EC, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7:11653. PMID: 27337592
   PubMed Web of Science ®Google Scholar
• Ussher JE, Willberg CB, Klenerman P. MAIT cells and viruses. Immunol Cell Biol. 2018;96(6):630–641. PMID: 29350807
   PubMed Web of Science ®Google Scholar
• Huang W, He W, Shi X, et al. Mucosal-associated invariant T-cells are severely reduced and exhausted in humans with chronic HBV infection. J Viral Hepat. 2020;27(11):1096–1107. PMID: 32510704
   PubMed Web of Science ®Google Scholar
• Leeansyah E, Ganesh A, Quigley MF. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013;121(7):1124–1135. PMID: 23243281
   PubMed Web of Science ®Google Scholar
• Leeansyah E, Svärd J, Dias J. Arming of MAIT cell cytolytic antimicrobial activity is induced by IL-7 and defective in HIV-1 infection. PLoS Pathog. 2015;11(8):e1005072. PMID: 26295709
   PubMed Web of Science ®Google Scholar
• Tang X, Zhang S, Sustained PQ. IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection. Sci Adv. 2020;6(8):eaaz0374. PMID: 32128419
   PubMed Web of Science ®Google Scholar
• Shih CK, Chen CM, Chen CY, et al. Riboflavin protects mice against liposaccharide-induced shock through expression of heat shock protein 25. Food Chem Toxicol. 2010;48(7):1913–1918. PMID: 20430062
   PubMed Web of Science ®Google Scholar
• Toyosawa T, Suzuki M, Kodama K, et al. Potentiation by amino acid of the therapeutic effect of highly purified vitamin B2 in mice with lipopolysaccharide-induced shock. Eur J Pharmacol. 2004;493(1–3):177–182. PMID: 15189780
   PubMed Web of Science ®Google Scholar
• Kodama K, Suzuki M, Toyosawa T, et al. Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice. Life Sci. 2005;78(2):134–139. PMID: 16112685
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Pochec E, Plytycz B. Immunomodulatory effect of riboflavin deficiency and enrichment-reversible pathological response versus silencing of inflammatory activation. J Physiol Pharmacol. 2015;66(6):793–802. PMID: 26769828
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Majka A, Wojtas L, et al. Strain-specific effects of riboflavin supplementation on zymosan-induced peritonitis in C57BL/6J, BALB/c and CBA mice. Life Sci. 2011;88(5–6):265–271. PMID: 21115019
   PubMed Web of Science ®Google Scholar
• Mazur-Bialy AI, Pocheć E. HMGB1 inhibition during zymosan-induced inflammation: the potential therapeutic action of riboflavin. Arch Immunol Ther Exp. 2016;64(2):171–176. PMID: 26445809
   PubMed Web of Science ®Google Scholar
• Saito H, Ebinuma H, Tada S, et al. Enhancing effect of the liver extract and flavin adenin dinucleotide mixture on anti-viral efficacy of interferon in patients with chronic hepatitis C. Keio J Med. 1996;45(1):48–53. PMID: 8882468
   PubMedGoogle Scholar
• Shahzad S, Ashraf MA, Sajid M, et al. Evaluation of synergistic antimicrobial effect of vitamins (A, B1, B2, B6, B12, C, D, E and K) with antibiotics against resistant bacterial strains. Journal of Global Antimicrobial Resistance. 2018(13):231–236.PMID: 29408383.
   Google Scholar
• Mal P, Dutta K, Bandyopadhyay D, et al. Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines. Inflamm Res. 2013;62(3):259–273. PMID: 23229721
   PubMed Web of Science ®Google Scholar
• Banerjee S, Ghosh D, Vishakha K, et al. Photodynamic antimicrobial chemotherapy (PACT) using riboflavin inhibits the mono and dual species biofilm produced by antibiotic resistant Staphylococcus aureus and Escherichia coli. Photodiagnosis Photodyn Ther. 2020;32:102002. PMID: 32916327
   PubMed Web of Science ®Google Scholar
• Rivas Aiello MB, Ghilini F, Martínez Porcel JE, et al. Riboflavin-mediated photooxidation of gold nanoparticles and its effect on the inactivation of bacteria. Langmuir. 2020;36(28):8272–8281. PMID: 32569473
   PubMed Web of Science ®Google Scholar
• Schrier A, Greebel G, Attia H, et al. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg. 2009;25(9):S799–802. PMID: 19772254
   PubMed Web of Science ®Google Scholar
• Hiraku Y, Ito K, Hirakawa K, et al. Photosensitized DNA damage and its protection via a novel mechanism. Photochem Photobiol. 2007;83(1):205–212. PMID: 16965181
   PubMed Web of Science ®Google Scholar
• Baier J, Maisch T, Maier M, et al. Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J. 2006;91(4):1452–1459. PMID: 16751234
   PubMed Web of Science ®Google Scholar
• Bäckman A, Makdoumi K, Mortensen J, et al. The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light. Acta Ophthalmol. 2014;92(7). PMID: 25493311
   PubMed Web of Science ®Google Scholar
• Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci. 2010;51(8):3950–3953. PMID: 20335618
   PubMed Web of Science ®Google Scholar
• Davis SA, Bovelle R, Han G, et al. Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane Database Syst Rev. 2020;6(6):CD013001. PMID: 32557558
   PubMedGoogle Scholar
• Li Z, Jhanji V, Tao X, et al. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. Br J Ophthalmol. 2013;97(5):669–671. PMID: 23355529
   PubMed Web of Science ®Google Scholar
• Said DG, Elalfy MS, Gatzioufas Z, et al. Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. 2014;121(7):1377–1382. PMID: 24576886
   PubMed Web of Science ®Google Scholar
• Bilgihan K, Kalkanci A, Ozdemir HB, et al. Evaluation of antifungal efficacy of 0.1% and 0.25% riboflavin with UVA: a comparative in vitro study. Curr Eye Res. 2016;41(8):1050–1056. PMID: 26644282
   PubMed Web of Science ®Google Scholar
• Prajna NV, Radhakrishnan N, Lalitha P, et al. Cross-linking-assisted infection reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis. Ophthalmology. 2020;127(2):159–166. PMID: 31619359
   PubMed Web of Science ®Google Scholar
• Kashiwabuchi RT, Carvalho FR, Khan YA, et al. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol. 2013;251(2):521–527. PMID: 23180236
   PubMed Web of Science ®Google Scholar
• Chan TC, Lau TW, Lee JW, et al. Corneal collagen cross-linking for infectious keratitis: an update of clinical studies. Acta Ophthalmol. 2015;93(8):689–696. PMID: 25990098
   PubMed Web of Science ®Google Scholar
• Arboleda A, Miller D, Cabot F, et al. Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol. 2014;158(1):64–70.e2. PMID: 24792103
   PubMed Web of Science ®Google Scholar
• Ragan I, Hartson L, Pidcoke H, et al. Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light. PLoS One. 2020;15(5):e0233947. PMID: 32470046
   PubMed Web of Science ®Google Scholar
• Keil SD, Ragan I, Yonemura S, et al. Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment. Vox Sang. 2020;115(6):495–501. PMID: 32311760
   PubMed Web of Science ®Google Scholar
• Keil SD, Bowen R, Marschner S. Inactivation of middle east respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion. 2016;56(12) PMID: 27805261
   Web of Science ®Google Scholar
• Faddy HM, Fryk JJ, Watterson D, et al. Riboflavin and ultraviolet light. impact on dengue virus infectivity. Vox Sang. 2016;111(3):235–241. PMID: 27281512
   PubMed Web of Science ®Google Scholar
• Cap AP, Pidcoke HF, Keil SD, et al. Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro. Transfusion. 2016;56:S6–15. Suppl 1 (Suppl1). PMID: 27001363.
   PubMed Web of Science ®Google Scholar
• Dey S, Bishayi B. Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation. J Inflamm. 2016;13(36). DOI:10.1186/s12950-016-0145-0. PMID: 27932936
   Google Scholar
• Tran JQ, Muench MO, Heitman JW, et al. Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes. Transfusion. 2019;59(11):3501–3510. PMID: 31599981
   PubMed Web of Science ®Google Scholar
• Van Dyck K, Viela F, Mathelié-Guinlet M, et al. Adhesion of Staphylococcus aureus to Candida albicans During Co-Infection Promotes Bacterial Dissemination Through the Host Immune Response. Front Cell Infect Microbiol. 2021 Feb;2(10):624839. PMID: 33604309.
   PubMed Web of Science ®Google Scholar
• Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–162. PMID: 21219181
   PubMed Web of Science ®Google Scholar
• Karki R, Sharma BR, Tuladhar S, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184(1):149–168.e17. PMID: 33278357
   PubMed Web of Science ®Google Scholar
• Salkowski CA, Detore G, McNally R, et al. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo: the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling. J Immunol. 1997;158(2):905–912. PMID: 8993010
   PubMed Web of Science ®Google Scholar
• Popescu M, Cabrera-Martinez B, Winslow GMTNF-Α. contributes to lymphoid tissue disorganization and germinal center B cell suppression during intracellular bacterial infection. J Immunol. 2019;203(9):2415–2424. PMID: 31570507
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5). PMID: 1940799
   Web of Science ®Google Scholar
• De Maio A. Heat shock proteins : facts, thoughts, and dreams.  Shock. 1999;11(1):1–12. PMID: 9921710.
   Google Scholar
• Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103. PMID: 21133840
   PubMed Web of Science ®Google Scholar
• Ouyang W, O’Garra A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. immunity. 2019;50(4):871–891. PMID: 30995504
   PubMed Web of Science ®Google Scholar